Background: Prematurity is a major risk factor for neonatal hearing loss. Recent advancements in magnetic resonance imaging (MRI) have made it possible to evaluate structural details of the membranous labyrinths in premature infants that have heretofore been inaccessible. Objective: We compared the prevalence of abnormal cochlear signal intensity in premature and term neonates and evaluated for a potential link with hearing loss. Materials and methods: We retrospectively reviewed 148 consecutive MR exams performed in premature (< 37 weeks' gestation) and term neonates performed over a 30-month period. Cochlear signal alteration was evaluated on threedimensional T1-weighted imaging (T1WI) sequences. Each patient's electronic medical record was reviewed to document demographics, symptomatology, physical exam findings, and potential medical variables that could contribute to cochlear signal alteration. Results: Cochlear hyperintensity on T1WI was present in 6.8% patients (n ¼ 10) overall, but was much more common in preterm than term patients (12.2% (9 of 74) vs. 1.4% (1 of 74), respectively; p value < 0.05; Fisher's exact test). Overall, 14.9% (n ¼ 15) of the patients with hearing test results failed the screening Auditory Brainstem Response exam. However, failure was much more common among patients with cochlear hyperintensity on T1W1 than those with normal findings (56% (5 of 9) vs. 11% (10 of 92), respectively; p value < 0.01; Fisher's exact test). Conclusion: Cochlear hyperintensity on T1WI is more common in preterm than term neonates, and potentially associated with hearing loss. Cochleae should be closely scrutinized in all premature infants; signal alterations should prompt further diagnostic inquiry and possible early otolaryngology referral.
Introduction
Prematurity has been shown to be a major risk factor for neonatal hearing loss. 1 Without early diagnosis and appropriate intervention, it has been shown that children with hearing loss will fail to keep pace with their hearing peers in terms of communication skills, academic achievement, and social-emotional development. 2 Currently, infants admitted to the neonatal intensive care unit (NICU) for more than five days are required to undergo screening for hearing loss with Auditory Brainstem Response (ABR) technology. 3 While imaging is not presently indicated for screening in this population, it may have a role in establishing a potential etiology for hearing loss once it is discovered through auditory testing.
Magnetic resonance imaging (MRI) has proven useful in the evaluation of inner ear pathology as a result of the contrast in signal generated from the juxtaposition of relatively higher signal intensity fluid and tissue contained within the membranous labyrinth and perilymphatic space with the relative lack of signal within the surrounding bony osseous labyrinth and adjacent air-filled mastoid air cells. 4 Prior case reports in adults have suggested a link between sensorineural hearing loss and abnormally increased cochlear signal intensity on T1-weighted imaging (T1W1). [5] [6] [7] [8] [9] Subacute hemorrhage and infection have been proposed as potential etiologies for hearing loss with associated abnormal MR signal, although other causes likely remain unknown.
The purpose of our study is to examine the prevalence of abnormal T1 signal intensity within the cochleae of preterm neonates in comparison to term neonates as well as to elucidate a possible connection of cochlear signal alteration with sensorineural hearing loss.
Material and methods
This institutional review board-exempted, Health Insurance Portability and Accountability Act (HIPAA)-compliant retrospective study examined MRIs of the brain performed over a 30-month period both at 1.5 and 3T in neonates and infants within three months of birth at a single tertiary care pediatric hospital. Brain MRIs from 74 consecutive term neonates (greater than or equal to 37 weeks' gestation) and 74 consecutive premature neonates (less than 37 weeks' gestation) were evaluated. Gestational age obtained from the electronic medical record was rounded down to the nearest week. The few patients with unknown gestational age were classified as term or preterm based on the presence or absence of term MR myelination pattern as previously described. 10 A total of 186 brain MRIs were reviewed; 36 were excluded because of motion artifact and two exams without pre-contrast T1WI were excluded. There was a broad range of indications for MRI with the most common including preoperative evaluation in neonates with congenital heart disease, seizure-like episode, neonatal encephalopathy, and further evaluation of abnormalities identified on prenatal imaging. This broad range of indications for MRI was similar both for preterm and term neonates. Notably, most neonates undergoing MRI prior to cardiac surgery were part of a separate study evaluating for intracranial structural abnormalities in patients with congenital heart disease.
All MR scans were performed on either a 1.5 or 3T MR (GE Healthcare, Milwaukee, WI). We reviewed coronal three-dimensional (3-D) volumetric T1WI as well as sagittal and axial multiplanar reconstructions. Coronal Coronal and axial MPR images were reconstructed at 2 mm slice thickness, no gap, with otherwise identical parameters. Standard spin echo T2WI were also acquired in each patient and evaluated for cochlear signal alterations. T2 fluid-attenuated inversion recovery (FLAIR) imaging is not performed at our institution as part of routine brain MR protocol under one year.
Images were reviewed on a picture archiving and communication system (PACS) workstation (Synapse; Fugifilm, Tokyo, Japan) in consensus by a radiologist with an American Board of Radiology subspecialty certificate in neuroradiology with a clinical practice of 100% pediatric neuroradiology and greater than five years of clinical experience after board certification as well as a pediatric radiology fellow. The reading radiologists were blinded to the patients' history and age at the time of imaging evaluation. We assessed scans for abnormal signal within the entire labyrinth including the cochlea and vestibule/semicircular canals. Signal intensity on T1W1 was deemed to be abnormally high if it subjectively appeared higher than the adjacent brain parenchyma. 4 Initially, neonates admitted to the NICU for more than five days underwent screening with automated Auditory Brainstem Response (ABR) testing as per the recommendation by the American Academy of Pediatrics. This examination measures cochlear response using a click stimulus in each ear, providing a pass/fail report without the need for audiologist interpretation. If a neonate failed ABR screening, the infant was referred for a comprehensive diagnostic (non-automated) ABR examination performed by an audiologist.
Each patient's electronic medical record was reviewed to document demographics, symptomatology, physical exam findings, audiometry results based on the ABR test, and potential medical variables that could contribute to cochlear signal alteration or failure of screening ABR. Discharge diagnoses in preterm neonates are listed in Table 1 .
Data storage and statistics
Data were stored and analyzed using a Microsoft Excel spreadsheet (Excel 2011; Microsoft, Redmond, WA). We compared discrete variables including presence vs. absence of abnormal cochlear signal, preterm (less than 37 weeks' gestation) vs. term (greater than or equal to 37 weeks' gestation) gestational age at birth, and 
Results
Of the 74 term neonates examined, the mean patient gestational age at birth was 38.9 weeks (range 37 to 41 weeks) with a median patient gestational age of 39 weeks. Of these, two had unknown gestational age by review of the electronic medical record and were classified as term by assessment of myelination pattern. Of the 74 preterm neonates examined, the mean patient gestational age at birth was 34.3 weeks (range 28 to 36 weeks) with a median patient gestational age of 35 weeks.
Cochlear hyperintensity on T1WI was present in 6.8% patients (n ¼ 10) (Figure 1 ). However, cochlear hyperintensity was much more common in preterm than term patients (12.2% (9 of 74) vs. 1.4% (1 of 74), respectively; p value < 0.05; Fisher's exact test) ( Figure 2 ). There was no significant difference between the percentage of patients with cochlear hyperintensity detected at 1.5 T (6.3%, 1/16) and 3T (6.8%, 9/132); p value ¼ 1, Fisher's exact test. No abnormal signal was identified within the remainder of the membranous labyrinth (vestibule and semicircular canals). The single term neonate with cochlear hyperintensity on T1WI had clinically documented meningitis and MRI evidence of subdural empyema. Five out of nine preterm neonates with cochlear hyperintensity on T1WI had MRI evidence of prior intraventricular hemorrhage.
Of the patients who had hearing test results available for review (n ¼ 101 of 148, 68%), 51% (n ¼ 52) were preterm and 49% (n ¼ 49) were term. Overall, 14.9% (n ¼ 15) of the patients with hearing test results failed the screening ABR exam. However, failure was much more common among patients with cochlear hyperintensity on T1W1 than those with normal findings (56% When only preterm neonates are taken into account, failure of screening ABR was more common in those with abnormal signal on T1WI than those with normal findings (63% (5 of 8) vs. 9% (4 of 44), respectively; p value < .01; Fisher's exact test). While failure of screening ABR in preterm neonates was more common in those on mechanical ventilation (28% 7 of 18) than in those without such intervention (7% 2 of 27), this finding (as compared to T1 signal) was not statistically significant at p > 0.07; Fisher's exact test).
For most of the five premature infants with abnormal cochlear signal and abnormal screening ABR, the abnormal cochlear signal corresponded to the side of failed ABR screening. Specifically, three patients had abnormal cochlear signal bilaterally and failed the ABR screening bilaterally. One patient had unilateral right abnormal cochlear signal and failed the ABR screening only on the right. One patient had unilateral left abnormal cochlear signal and failed the ABR screening bilaterally. Of the top four discharge diagnoses (congenital heart disease, respiratory failure, encephalopathy without and with hypoxia/ischemia), there is no significant association with hearing loss in our cohort (p ! 0.09 for all of the above, Fisher's exact test).
Follow-up after failure of screening ABR was limited. Of the five preterm neonates who failed the screening ABR, two passed the subsequent diagnostic ABR examination and the remaining three have no record of follow-up in our system.
Discussion
The organ of hearing, the cochlea, is an inner ear structure formed by portions of the bony labyrinth, a series of interconnected spaces within the petrous temporal bone, and the membranous labyrinth, which consists of interlinked membranous sacs and ducts that are positioned within the bony labyrinth. Within the bony labyrinth of the cochlea, perilymph, a clear fluid with composition similar to cerebrospinal fluid, fills spaces called the scala tympani and scala vestibuli. These spaces surround the membranous labyrinth of the cochlea or scala media, which is filled with endolymph, a clear fluid with composition similar to cytosol. 11 It is these inner ear fluids that normally generate signal intensity that is isointense to hypointense to brain parenchyma on T1WI and hyperintense to brain on T2WI. 4 Prior case reports in adults have either suggested or shown that abnormally increased signal intensity within the cochlea on T1WI may be related to hemorrhage, infection, increased protein within perilymph or endolymph, and inner ear lipoma. [5] [6] [7] [8] [9] Regarding spontaneous hemorrhage into the inner ear, it has been demonstrated that hemolabyrinth can have a variety of causes, although it typically occurs in association with hemorrhagic diatheses or diseases characterized by hemorrhage in their terminal stages. Inner ear hemorrhage in leukemia, for instance, is well documented in the literature. Reports have also shown hemolabyrinth in association with head trauma without fracture of the bony labyrinth. 12 A case report has shown abnormally increased cochlear T1-weighted signal intensity in a patient with presumed hemorrhagic labyrinthitis as a result of documented streptococcus suis meningitis. 6 It is believed that the bacteria can enter the perilymph via the cochlear aqueduct through lytic actions of exotoxins, which has been shown in animal models. 13 The cochlear aqueduct, which connects the perilymphatic space of the cochlea with the subarachnoid space of the posterior cranial cavity, has been shown to demonstrate a short, straight, and patent course in newborns. 14 Notably, the only term infant in our study with abnormal cochlear signal had documented meningitis. Casselman et al. discuss the importance of obtaining pre-contrast T1WI in order to distinguish spontaneous hyperintensity from enhancement, which can be seen in cases of inflammation or neoplasm. 8 A majority of the aforementioned studies demonstrate abnormally increased T1-weighted cochlear signal intensity in adult patients with hearing loss. Our study strove to document the prevalence of abnormal cochlear signal intensity in premature infants, who are known to be at greater risk for hearing loss than the general population. 3 Moreover, the prevalence of neonatal hearing loss has shown to increase with decreasing week of gestation. 1 We also documented a potential link between this abnormal cochlear signal intensity and hearing loss as measured by screening ABR testing, which is recommended by the Joint Committee on Infant Hearing (JCIH) as the only appropriate screening technique for use in the NICU. 3 It should be noted that there are a variety of documented risk factors for hearing impairment in premature infants, many of which likely exert their deleterious effects along points in the auditory pathway other than the inner ear. For instance, bilirubin selectively damages brainstem auditory nuclei and the auditory nerve, with sparing of the inner ear. 15 Other risk factors for hearing impairment in premature infants include early gestational age, low birth weight, mechanical ventilation, neurotoxic medications, and septicemia. 16 Mark et al. summarizes the point that in patients with sensorineural hearing loss, the entire auditory pathway including the labyrinth, internal auditory canal, cerebellopontine angle, and brainstem should be carefully scrutinized. 17 Early diagnosis and intervention for sensorineural hearing loss is imperative in order to prevent those affected from falling behind their hearing peers in speech, language, cognitive, and academic skills. 18 The current favored treatment for profound sensorineural hearing loss is auditory rehabilitation using a cochlear implant. Mounting evidence has demonstrated that earlier implantation (as early as four months) can have a profound effect on language skills and auditory performance. 2 It is likely too early to say what the exact role of MRI should be in the evaluation both of preterm and term neonates. While T1 hyperintensity may be a better predictor of failed screening ABR than some variables including discharge diagnosis or mechanical ventilation, at present imaging is not indicated for screening of hearing loss. However, an MRI including submillimeter T1 images through the temporal bones may be useful once a patient fails his or her screening or subsequent diagnostic ABR examination in order to further elucidate a potential cause for hearing loss (previous intracranial hemorrhage or meningitis in the setting of abnormal cochlear signal). At the very least, we believe that the radiologist should pay close attention to the cochlea for abnormal T1 hyperintensity in all preterm neonates imaged while in the NICU. Along with ABR testing, the imaging findings may play a complementary role in prompting further auditory testing and/or early otolaryngology referral for potential treatment.
Limitations of this study include the fact that more than one-third of patients evaluated for abnormal MRI signal intensity either did not undergo or we did not have records of ABR screening. In addition, the ABR test itself is not specific for cochlear pathology. Therefore, it is possible that the hearing loss in those premature neonates with abnormal ABR exam (who also had MRI findings of hypoxic-ischemic encephalopathy) is extra-cochlear in etiology. Further studies evaluating the relationship between abnormal cochlear signal and hearing loss using auditory tests specific to cochlear pathology (otoacoustic emissions and/or electrocochleography) are warranted.
Further study limitations include the fact that histological confirmation of inner ear pathology among neonates with abnormal cochlear signal was not possible. Two patients had no gestational age on record and could have potentially been misclassified; however, these were both consistent with term exams on the basis of normal term myelination patterns. Lastly, our study included a relatively small sample size as well as a solitary reviewer, which precludes assessment for interobserver variability.
Conclusion
Cochlear hyperintensity on T1WI is more common in preterm than term patients, and potentially associated with hearing loss. Possible etiologies of this abnormal signal include hemorrhage and infection. We believe the cochleae should be closely scrutinized in all preterm neonates imaged while in the NICU. Patients with signal alterations may benefit from further auditory diagnostic examinations and early otolaryngology referral for potential treatment.
